VANCOUVER – Telus said this week that the statutory waiting period under the pre-merger notification provisions of the Competition Act (Canada) expired on December 17, 2007 in connection with its offer to buy all of the common shares of Emergis Inc. for $8.25 in cash.
As well, announced Telus, the Commissioner of Competition has also advised that she does not intend to challenge the $763 million transaction announced late November, under the merger provisions of the Competition Act.
“This fulfills the condition of the Offer relating to the Competition Act (Canada), but the Offer continues to be subject to the other conditions set forth in the Offer and the offering circular dated December 11, 2007. The Offer is scheduled to be open for acceptance until 5:00 p.m. (Eastern Standard Time) on January 16, 2008, unless withdrawn or extended,” explains the press release.
Emergis has a strong presence in both health claims processing and pharmacy management systems in Canada. Emergis’ electronic health record systems for the exchange, integration, sharing, and retrieval of electronic health information, are considered best-of-breed. It was a Bell Canada Enterprises division until 2005, when it was spun off.
